Business Opportunities for Telemedicine During COVID-19 (pre-order)

Abstract

Since early 2020, the world has been hit hard by the COVID-19 outbreak with new confirmed cases continuing to rise. Health systems worldwide have been overwhelmed with patients and people are worried about the risk of infection when going to hospitals. As a result, demand for telemedicine services has surged. This report discusses international policies, application services, business opportunities in the value chain, and key issues associated with telemedicine in recent years

Lists of Topics

Development of telemedicine around the world, touching on international policies in North America, Europe, and Asia

Telemedicine application services in virtual medical consultation with examples of Teladoc Health and AmWell, in digital diagnostics with examples of Tyto Care and Healthy.io, in digital pharmacy with examples of Amazon Care and Ali Health, and in Telecare with examples of Philips eICU and XR Health

Business opportunities in telemedicine value chain from end devices, network communications, to application services, and includes two key issues in telemedicine

Companies covered

Accenture Canada, Ali Health, Alibaba, Allianz X, AmWell, Apple, Babylon Health, Facebook, Google, Healthy.io, LifeLabs, Oasis Medical, Orion Health, Philips, PillPack, RGAX, Roche Canada, Skype, Teladoc Health, TELUS Health, TMall Pharma, Tyto Care, Under Armour, XRHealth

Table Of Contents

1.Preface 

2.International Polices 

2.1 North America 

2.1.1 The United States 

2.1.2. Canada 

2.2 Europe 

2.1.1 Germany 

2.1.2 UK 

2.1.3 France 

2.2 Asia 

2.2.1 China 

2.2.2 Japan 

3.Application Services 

3.1 Virtual Medical Consultation 

3.1.1 Teladoc Health 

3.1.2 AmWell 

3.2 Digital Diagnostics 

3.2.1 Tyto Care 

3.2.2 Healthy.io 

3.3 Digital Pharmacy 

3.3.1 Amazon Care 

3.3.2 Ali Health 

3.4 Telecare 

3.4.1 Philips eICU 

3.4.2 XR Health 

4.Business Opportunities in Telemedicine Value Chain 

4.1 End Devices: In-home Biometric Devices Have Great Growth Potential 

4.2 Network Communications: Increased Data Transmission in Hospitals Boosts Inelastic Demand 

4.3 Application Services: Telemedicine as a Key Risk Control Technique in the Post-pandemic Era 

5.Key Issues 

5.1 Improvement in Adaptability of Telemedicine Regulations is Required 

5.2 Urgent Needs for Comprehensive Protection of Personal Health Data 

6.MIC Perspective 

Appendix 

List of Companies 

List of Figures

Figure 1 Teladoc Health 

Figure 2 AmWell 

Figure 3 Tyto Care’s Digital Stethoscope 

Figure 4 Healthy.io’s Urine Testing Device 

Figure 5 Amazon Care 

Figure 6 Ali Health 

Figure 7 Philips eICU’s Telecare Center 

Figure 8 XRHealth 

Figure 9 Telemedicine Industry Value Chain 

 List of Table

Table 1 Number of COVID-19 Cases in G7 and BRICS Countries